1. Srinakharinwirot University Institutional Repository
  2. Articles from Academic Databases : SCOPUS
  3. Scopus 1983-2021
Please use this identifier to cite or link to this item: https://ir.swu.ac.th/jspui/handle/123456789/14896
Full metadata record
DC FieldValueLanguage
dc.contributor.authorManosuthi W.
dc.contributor.authorSungkanuparph S.
dc.contributor.authorRuxrungtham K.
dc.contributor.authorPrasithsirikul W.
dc.contributor.authorAthichathanabadi C.
dc.contributor.authorTantisiriwat W.
dc.contributor.authorBowonwatanuwong C.
dc.contributor.authorChumpathat N.
dc.contributor.authorChaovavanich A.
dc.date.accessioned2021-04-05T04:32:04Z-
dc.date.available2021-04-05T04:32:04Z-
dc.date.issued2008
dc.identifier.issn15254135
dc.identifier.other2-s2.0-39049117418
dc.identifier.urihttps://ir.swu.ac.th/jspui/handle/123456789/14896-
dc.identifier.urihttps://www.scopus.com/inward/record.uri?eid=2-s2.0-39049117418&doi=10.1097%2fQAI.0b013e318157b0da&partnerID=40&md5=9c6cb1be2c5626aefcfeb310a21297cf
dc.description.abstract[No abstract available]
dc.subjectatazanavir
dc.subjectproteinase inhibitor
dc.subjectritonavir
dc.subjectRNA directed DNA polymerase inhibitor
dc.subjectsaquinavir
dc.subjectvirus RNA
dc.subjectatazanavir
dc.subjectoligopeptide
dc.subjectproteinase inhibitor
dc.subjectpyridine derivative
dc.subjectritonavir
dc.subjectsaquinavir
dc.subjectadult
dc.subjectaminotransferase blood level
dc.subjectblood sampling
dc.subjectCD4 lymphocyte count
dc.subjectclinical article
dc.subjectcontrolled study
dc.subjectDNA polymorphism
dc.subjectdrug blood level
dc.subjectdrug efficacy
dc.subjectdrug safety
dc.subjectdrug tolerability
dc.subjectdyslipidemia
dc.subjectfemale
dc.subjecthigh performance liquid chromatography
dc.subjecthuman
dc.subjectHuman immunodeficiency virus infection
dc.subjecthyperbilirubinemia
dc.subjectletter
dc.subjectlow drug dose
dc.subjectmale
dc.subjectpractice guideline
dc.subjectpriority journal
dc.subjectsalvage therapy
dc.subjectside effect
dc.subjectsteady state
dc.subjecttreatment duration
dc.subjecttreatment outcome
dc.subjectvirus resistance
dc.subjectarticle
dc.subjectdrug administration
dc.subjectdrug combination
dc.subjectDrug Administration Schedule
dc.subjectDrug Therapy, Combination
dc.subjectHIV Infections
dc.subjectHIV Protease Inhibitors
dc.subjectHumans
dc.subjectOligopeptides
dc.subjectPyridines
dc.subjectRitonavir
dc.subjectSaquinavir
dc.titlePlasma levels, safety, and 60-week efficacy of a once-daily double-boosted protease inhibitor regimen of atazanavir, saquinavir, and ritonavir
dc.typeLetter
dc.rights.holderScopus
dc.identifier.bibliograpycitationJournal of Acquired Immune Deficiency Syndromes. Vol 47, No.1 (2008), p.127-129
dc.identifier.doi10.1097/QAI.0b013e318157b0da
Appears in Collections:Scopus 1983-2021

Files in This Item:
There are no files associated with this item.
Show simple item record


Items in SWU repository are protected by copyright, with all rights reserved, unless otherwise indicated.